Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v3-EN | Version v2-FR |
|---|---|---|
| Language | English (Updated) | French |
| Date Updated | 2026-04-18 (Updated) | 2026-04-16 |
| Drug Identification Number | 02441829 | 02441829 |
| Brand name | TOUJEO SOLOSTAR | TOUJEO SOLOSTAR |
| Common or Proper name | insulin glargine injection | insulin glargine injection |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | INSULIN GLARGINE | INSULIN GLARGINE |
| Strength(s) | 300UNIT | 300UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 3 x 1.5 mL pen | 3 x 1.5 mL pen |
| Anatomical Therapeutical Chemical (ATC) code | A10AE | A10AE |
| Anatomical Therapeutical Chemical (ATC) description | INSULINS AND ANALOGUES | INSULINS AND ANALOGUES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2026-04-16 | 2026-04-16 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Supply Delay The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. | Supply Delay The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments |